| For: | Zorzopulos J, Opal SM, Hernando-Insúa A, Rodriguez JM, Elías F, Fló J, López RA, Chasseing NA, Lux-Lantos VA, Coronel MF, Franco R, Montaner AD, Horn DL. Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. World J Stem Cells 2017; 9(3): 45-67 [PMID: 28396715 DOI: 10.4252/wjsc.v9.i3.45] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i3/45.htm |
| Number | Citing Articles |
| 1 |
Cheng Ju, Renfeng Liu, Yu Zhang, Feifei Zhang, Jun Sun, Xiao-Bin Lv, Zhiping Zhang. Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management. BioMed Research International 2019; 2019 doi: 10.1155/2019/7695768
|
| 2 |
Stefania Bianchi, Verónica C. Martínez Allo, Milena Massimino, María Del R. Lavignolle Heguy, Francisco R. Borzone, Sofía Gomez Bustillo, Norma A. Chasseing, Carlos Libertun, Alejandro D. Montaner, Gabriel A. Rabinovich, Marta A. Toscano, Victoria A. Lux-Lantos, María S. Bianchi. Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice. Nucleic Acid Therapeutics 2021; 31(2) doi: 10.1089/nat.2020.0901
|
| 3 |
Mailín Casadei, Bernardo Miguel, Julia Rubione, Esteban Fiore, Diego Mengelle, Roberto A. Guerri-Guttenberg, Alejandro Montaner, Marcelo J. Villar, Luis Constandil-Córdova, Alfonso E. Romero-Sandoval, Pablo R. Brumovsky. Mesenchymal Stem Cell Engagement Modulates Neuroma Microenviroment in Rats and Humans and Prevents Postamputation Pain. The Journal of Pain 2024; 25(8) doi: 10.1016/j.jpain.2024.03.004
|
| 4 |
Candelaria Leiguarda, María Florencia Coronel, Alejandro Daniel Montaner, Marcelo José Villar, Pablo Rodolfo Brumovsky. Long-lasting ameliorating effects of the oligodeoxynucleotide IMT504 on mechanical allodynia and hindpaw edema in rats with chronic hindpaw inflammation. Neuroscience Letters 2018; 666 doi: 10.1016/j.neulet.2017.12.032
|
| 5 |
Patricia A. Mathieu, Yim Rodriguez Sampertegui, Fernanda Elias, Alexis Silva Silva, María de Luján Calcagno, Ricardo López, Ana M. Adamo. Oligodeoxynucleotide IMT504: Effects on Central Nervous System Repair Following Demyelination. Molecular Neurobiology 2024; 61(7) doi: 10.1007/s12035-023-03825-7
|
| 6 |
Graciela L. Mazzone, María F. Coronel, Miranda Mladinic, Cynthia Sámano. An update to pain management after spinal cord injury: from pharmacology to circRNAs. Reviews in the Neurosciences 2023; 34(6) doi: 10.1515/revneuro-2022-0089
|
| 7 |
Candelaria Leiguarda, Constanza Potilinski, Julia Rubione, Pablo Tate, Marcelo J. Villar, Alejandro Montaner, Verónica Bisagno, Luis Constandil, Pablo R. Brumovsky. IMT504 Provides Analgesia by Modulating Cell Infiltrate and Inflammatory Milieu in a Chronic Pain Model. Journal of Neuroimmune Pharmacology 2021; 16(3) doi: 10.1007/s11481-020-09971-2
|
| 8 |
Midori Maeda, Taisuke Kojima, Yang Song, Shuichi Takayama. DNA‐Based Biomaterials for Immunoengineering. Advanced Healthcare Materials 2019; 8(4) doi: 10.1002/adhm.201801243
|
| 9 |
Maximiliano Borda, Romina Sierra, María José Cantero, Sofía Gómez Bustillo, Esteban Juan Fiore, Gianlucca Giardelli, Matías Martino Garcet, María Luz Rebottaro, Juan Miguel Bayo Fina, Máximo Schiavone, Julia Rubione, Mariana Gabriela García, Alejandro Montaner, Guillermo Daniel Mazzolini, Jorge Benjamín Aquino. The antifibrotic potential of IMT504: modulation of GLAST + Wnt1 + bone marrow stromal progenitors and hepatic microenvironment. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03896-w
|